MEDGINTRAS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 1,996,464 | 2,561,919 | 2,945,313 | 3,727,510 | 5,876,192 | 7,835,670 | 9,166,184 | 9,151,878 |
| Profit before tax | 181,046 | 159,224 | 465,217 | 183,702 | 340,005 | 1,470,020 | 1,573,546 | 633,581 |
| Net profit | 173,409 | 151,600 | 449,044 | 143,006 | 315,642 | 1,386,410 | 1,501,898 | 525,914 |
| Equity | 204,946 | 193,637 | 634,870 | 474,543 | 647,179 | 1,417,947 | 2,919,845 | 3,445,758 |
| Liabilities | 193,578 | 460,666 | 0 | 750,723 | 719,823 | 672,111 | 893,400 | 1,309,015 |
| Non-current assets | 104,722 | 215,421 | 335,629 | 422,623 | 356,715 | 319,444 | 949,833 | 2,300,718 |
| Current assets | 306,044 | 489,711 | 635,002 | 875,227 | 1,066,657 | 1,815,520 | 2,893,631 | 2,495,593 |
| Total assets | 410,766 | 705,132 | 970,631 | 1,297,850 | 1,423,372 | 2,134,964 | 3,843,464 | 4,796,311 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,157,948 | 1,216,623 | 1,275,925 |
| Social insurance contributions | - | - | - | - | - | 1,041,401 | 1,195,438 | 1,343,036 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +19.4% | +28.3% | +15.0% | +26.6% | +57.6% | +33.3% | +17.0% | -0.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 42.2% | 21.5% | 46.3% | 11.0% | 22.2% | 64.9% | 39.1% | 11.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 84.6% | 78.3% | 70.7% | 30.1% | 48.8% | 97.8% | 51.4% | 15.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 8.7% | 5.9% | 15.2% | 3.8% | 5.4% | 17.7% | 16.4% | 5.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 9.1% | 6.2% | 15.8% | 4.9% | 5.8% | 18.8% | 17.2% | 6.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.9 | 2.4 | - | 1.6 | 1.1 | 0.5 | 0.3 | 0.4 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 20,547 | 25,015 | 26,084 | 27,731 | 28,758 | 34,877 | 40,159 | 37,649 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
MEDGINTRAS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-11-18 | 2025-11-24 | 115051.69 |
| 2025-10-16 | 2025-10-22 | 114759.53 |
| 2024-11-18 | 2024-12-15 | 0.01 |
| 2024-10-29 | 2024-11-13 | 0.01 |
| 2024-10-24 | 2024-10-27 | 0.01 |
| 2022-11-17 | 2022-11-18 | 304.51 |
| 2021-10-26 | 2021-11-02 | 28.39 |
MEDGINTRAS - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-06-17 | 2025-06-18 | 37.64 |
| 2025-06-14 | 2025-06-16 | 844.52 |
| 2025-05-08 | 2025-05-08 | 11.6 |
| 2025-05-05 | 2025-05-07 | 10.9 |
| 2025-05-03 | 2025-05-04 | 15.4 |
| 2025-05-01 | 2025-05-02 | 1308.9 |
| 2025-04-04 | 2025-04-14 | 38.25 |
| 2025-04-02 | 2025-04-03 | 36.58 |
| 2025-02-20 | 2025-02-20 | 65.76 |
| 2024-12-12 | 2024-12-12 | 1013.6 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MEDGINTRAS, UAB (company code 160289489) is a Private Limited Liability Company engaged in Medical specialists activities. In the latest financial year, 2025, the company generated revenue of €9.15M and net profit of €525.9K, with a profit margin of 5.7%. Revenue was broadly unchanged from 2024, when it reached €9.17M, while profit was lower than in 2024, when net profit stood at €1.50M. Compared with 2023, however, revenue increased from €7.84M, showing two-year growth of 16.8%. Over the same period, profitability eased from €1.39M in 2023 and €1.50M in 2024 to the 2025 level. At the end of 2025, total assets were €4.80M, equity €3.45M and liabilities €1.31M. The balance sheet remained strongly equity-backed, with an equity ratio of 71.8% and debt-to-equity of 0.38. Asset turnover was 1.91x. Revenue per employee was €37.7K and profit per employee €2.2K.